The concentrations of androstenedione, testosterone, oestrone and oestradiol-17\g=b\ were measured in peripheral and ovarian venous blood and follicular fluid of women at various stages of the menstrual cycle. The concentration of oestradiol was similar in small follicles (diameter < 8 mm) at all stages of the menstrual cycle and in large follicles (diameter \ m=ge\8 mm) except during the mid-and late follicular phase when the concentration reached a peak (\m=~\ 1500 ng/ml).
INTRODUCTION
Human ovarian tissue incubated in vitro has the capacity to synthesize androgens as well as oestrogens and gestagens (Savard, Marsh & Rice, 1965) . Although at least three androgens (testosterone, androstenedione and dehydroepiandrosterone) are known to be secreted by the human ovary in vivo (Baird, 1971 for review) there is very little knowledge about the amounts of androgens present in normal follicular fluid (Short & London, 1961;  Giorgi, 1965 ;  de Jong, Baird & van der Molen, 1974) .
In the present paper the secretion of testosterone, androstenedione, oestradiol-17/? and oestrone by the human ovary in vivo has been studied by measuring the concentration of these steroids in follicular fluid, and peripheral and ovarian venous plasma obtained from women at different stages of the menstrual cycle.
The indications for surgery were stage 0 carcinoma of the cervix (19 women), menorrhagia due to fibroids (36), dysfunctional uterine bleeding (8), endometriosis (14) , or chronic pelvic pains or dysmenorrhoea (30) . Those with stage 0 carcinoma of the cervix had regular menstrual cycles (24-33 days) and were considered to be endocrinologically normal (Baird & Fraser, 1974) . The (Baird, 1971) .
Radioimmunoassay of steroid hormones
Androstenedione Antiserum supplied by Dr W. Schopman, Rotterdam, The Netherlands, for the assay of androstenedione was raised in rabbits immunized with lla-hydroxy-4-androstene-3,17-dione-hemisuccinate coupled to bovine serum albumin. Cross-reactions of other steroids in the assay were : 11/î-hydroxyandrostenedione, 36 % ; andrenosterone, 43 % ; and testo¬ sterone, 0-3 %. The assay for androstenedione in plasma and follicular fluid differed from that described by Baird, Burger, Heavon-Jones & Scaramuzzi (1974) alumina column previously washed sequentially with 3-2 ml ethanol, 6-4 ml methanol, 4-8 ml dichloromethane and methanol (1 :1, v/v) and 4-8 ml dichloromethane. The sample was allowed to run through the column which was then washed with a further 2-4 ml hexane and ether (4:1, v/v) and also 6-4 ml 0-1 % ethanol in hexane. The androstenedione fraction was then eluted with 3-2 ml 1-0 % ethanol in hexane. The eluate was evaporated to dryness and dissolved in 0-5 ml phosphate buffer (0-1 mol/1, pH 7-0) containing 0-1 % gelatin. An aliquot (0-1 ml) was removed for estimating the recovery of [l,2-3H] for this assay was raised in a goat immunized with testosterone-3-(0-carboxymethyl) oxime-bovine serum albumin conjugate. Cross-reactions of other steroids in this assay were: 5a-dihydrotestosterone, 25%; oestradiol-17/?, 0-20%; androstenedione, 0-08%.
The assay for testosterone in plasma and follicular fluid was that described by Corker & Davidson (1976) . The results of measurements of testosterone after a single extraction of 50 or 20 µ\ of follicular fluid were not significantly different from those obtained after extraction and Chromatographie separation (P > 0-1, 6 observations, paired /-test). The assays were carried out in duplicate and the minimum detectable level of testosterone in peripheral and ovarian venous plasma and follicular fluid was 0-2 ng/ml.
Oestrone
The antiserum used for this assay was raised in rabbits against an oestrone-6-(0-carboxymethyl) oxime-bovine serum albumin conjugate. Cross-reactions of other steroids in this assay were : oestradiol-17/?, 3-0 % ; oestriol, 0-3 % ; testosterone, < 0-001 % ; progesterone, < 0-001 % ; androstenedione, < 0-001 %. Follicular fluid was assayed without extraction, since there was no difference in values when compared with assays on other extracts (P > 0-1, Student's ?-test, = 12). Plasma samples were extracted as described by Bolton & Rutherford (1976) before assay.
For assay, plasma extracts or 0-25 ml aliquots of follicular fluid, previously diluted 50-to 1000-fold in 005 M-phosphate buffer (pH 7-0) containing 0-2 % gelatin, 1 /¿g stilboestrol/ml (to minimize non-specific binding of steroids) and 15 % sucrose, were added to assay tubes, followed by 2-5 pg of [2,4,6,7-3H] oestrone, 116 Ci/mmol (The Radiochemical Centre, Amersham), which was added in 0-05 ml assay buffer. A suspension of antiserum (0-2 ml) covalently coupled to cellulose was then added at a dilution to bind about 70 % of the tracer. After mixing gently and standing overnight at room temperature, the antibody-bound steroid was separated from the free steroid by centrifugation, and the supernatant (free) fraction was counted by liquid scintillation. The use of a diluent containing a high concen¬ tration of sucrose minimized settling of the solid-coupled antibody and thus obviated the necessity for continuous agitation of the assay tubes (Bolton, Dighe & Hunter, 1975 Ovarian venous plasma In every sample, the concentrations of oestradiol, oestrone, testosterone and androstene¬ dione were higher than the corresponding value in peripheral plasma indicating secretion by the ovary. The concentrations of androgens and oestrogens draining the ovary containing a large follicle in the late follicular phase and the corpus luteum in the luteal phase, were higher than the concentrations iij the contralateral ovarian vein (Table 2) . However, the concentration of steroids in plasma draining the contralateral ovaries was similar to that draining both ovaries in the early follicular phase of the cycle.
Follicular fluid
The concentrations of oestrogens and androgens in the antral fluid of follicles aspirated in situ were not significantly different from those aspirated in vitro (P > 005). The results obtained for each hormone from the two methods of collection have therefore been pooled, and concentrations (mean ± 1 s.e.m.) in all antral fluids in relation to follicle size and the stage of the menstrual cycle are shown in Table 3 .
The concentration of androstenedione in follicular fluid was between 100 and 500 times higher than in peripheral plasma. It was not significantly different between large (^8 mm) and small ( < 8 mm) follicles, except during the late follicular phase when the concentration in large follicles was significantly lower than that in the small follicles ( < 005). The con¬ centration of testosterone was between 10 and 3000 times higher than that in peripheral plasma. In large follicles during the follicular phase the concentration was relatively constant at 25-30 ng/ml ; the concentration of testosterone in small follicles was higher and reached a peak (104 + 22 (s.e.m.) ng/ml) at mid-cycle. (10) (1) (1 , was similar to that described for normal women during the menstrual cycle ).
These studies confirm that, in addition to oestrogens (Short, 1964) , the Graafian follicle contains large amounts of androgens, especially androstenedione. Indeed it is only the large follicles during the follicular phase in which the concentration of androstenedione is less than that of oestradiol (Table 3 ). The concentrations of oestradiol-17/? and oestrone in antral fluid throughout the menstrual cycle were similar to those described by Smith (I960), Short & London (1961 ), Sanyal et al. (1974 , Baird & Fraser (1975) and . The ratio of oestradiol to oestrone in antral fluid was similar to that described by Baird & Fraser (1975) By relating the concentration of steroids in ovarian venous plasma to the presence or absence of a large follicle or corpus luteum, it is possible to obtain some information about the secretory activity of these structures in vivo (Baird, 1973) . The marked rise in the con¬ centration of steroids in the vein draining the ovary containing a preovulatory follicle or a corpus luteum, confirms that both these structures secrete large amounts of oestradiol and androstenedione (Table 3 ; . The rise in the concentration of testosterone and androstenedione in peripheral plasma at mid-cycle is similar to that reported from this ) and other laboratories (Judd & Yen, 1973) . Assuming a mean ovarian blood flow of 21 ml/min (Baird & Fraser, 1974) , the calculated secretion of androstenedione (1-7 mg/24 h) from the ovary containing the preovulatory follicle could account for all the increased blood production of androstenedione at mid-cycle (Baird, 1974) . The blood pro¬ duction rate of testosterone, calculated from the product of the peripheral plasma concen¬ tration and the mean metabolic clearance rate (Baird, Horton, (Leymarie & Savard, 1968 (Baird et al. 1974) and also when added to incubations of ovarian tissue in vitro (Savard et al. 1965 It is of interest to note that while the concentration of oestradiol is very much higher than that of androstenedione in follicular fluid during the mid-and late follicular phase the con¬ verse is true in ovarian venous blood. These observations confirm those of Short (1964) and YoungLai & Short (1969) for the mare. The high concentrations of steroids within the follicle probably play an important role locally in regulating follicular development. Oestrogen sensitizes the ovary to the effects of gonadotrophin (Bradbury, 1961 ;  Goldenberg, Vaitukaitis & Ross, 1972) possibly by increasing the number of receptor sites on the granulosa cells for LH (Channing & Kammerman, 1974) . High follicular concentrations of oestradiol together with FSH enhances both the mitotic activity and the biosynthetic capac¬ ity of granulosa cells in vitro . By contrast, local application of testosterone to the ovary inhibits follicular development (Payne & Runsen, 1958) and recent evidence suggests that LH may stimulate the production of testosterone by the interstitial cells of the ovary and thereby inhibit follicular growth (Louvet, Harman, Schreiber & Ross, 1975 
